• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Davey Daniel Hits the High Points of the OneOncology Annual Conference

Video

The OneOncology Annual Conference is being held November 11-13 in Nashville, Tennessee, and brings together practice leaders, physicians, and advanced practice providers to discuss the business of oncology and scientific advancements, explained Davey Daniel, MD, chief medical officer of OneOncology.

The OneOncology Annual Conference is being held November 11-13 in Nashville, Tennessee, and brings together practice leaders, physicians, and advanced practice providers to discuss the business of oncology and scientific advancements, explained Davey Daniel, MD, chief medical officer of OneOncology.

Transcript

How does the OneOncology annual conference serve the participating physicians?

We're really excited about our OneOncology annual conference that we're holding. We're bringing together practice leaders and physicians and even our APP [advanced practice provider] team members into Nashville to spend time together, but also to discuss changes in the business of oncology, along with the science that's advancing in different specialties.

We're spending about a day and a half on where breast cancer, lung cancer, leukemias are going in the near future. We’ve asked the speakers to spend a little time almost forecasting where they think we'll be in a couple of years. The business section is also very exciting. We're getting a lot of input from our practice leaders, but also we're lucky that Nashville is a huge mecca for health care innovation, and we're going to be tapping into some of that as well.

What current issues in oncology management are you hearing about from your member practices and how are you addressing these in the conference program?

There are a lot of headwinds in oncology, both from the increased challenges of value-based care and preparing for EOM, the Enhancing Oncology Model. But also, how do we deal with changes in the payer makeup? How are we going to address the challenges that PBMs [pharmacy benefit managers] face to our practice? We'll be spending a lot of time discussing those challenges.

But we're also going to be spending some time on things like precision medicine, how do we really address the large volume of information that's coming at physicians, and how, as a network, we can actually leverage our centralized resources to make it easier for doctors to perform, to take care of patients, which is really what we're all there for.

Related Videos
Debra Boyer, MD, MHPE, ATSF.
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
Screenshot of Stephen Freedland, MD, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.